H1N Stock Overview
Metasphere Labs Inc. focus on leveraging blockchain, metaverse, and AI technologies. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Metasphere Labs Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.093 |
| 52 Week High | CA$3.28 |
| 52 Week Low | CA$0.085 |
| Beta | 4.6 |
| 11 Month Change | -13.27% |
| 3 Month Change | -25.76% |
| 1 Year Change | -42.00% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| H1N | DE Software | DE Market | |
|---|---|---|---|
| 7D | -7.2% | 2.1% | 0.8% |
| 1Y | -42.0% | 53.9% | 9.1% |
Return vs Industry: H1N underperformed the German Software industry which returned 55.4% over the past year.
Return vs Market: H1N underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| H1N volatility | |
|---|---|
| H1N Average Weekly Movement | 17.7% |
| Software Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: H1N's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: H1N's weekly volatility has decreased from 35% to 18% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Natasha Ingram | www.metasphere.earth |
Metasphere Labs Inc. focus on leveraging blockchain, metaverse, and AI technologies. The company provides ClimateBot, a digital platform equipped with calculators designed to assess environmental impacts on calculating carbon footprints; and CarbonBot. The company was formerly known as Looking Glass Labs Ltd.
Metasphere Labs Inc. Fundamentals Summary
| H1N fundamental statistics | |
|---|---|
| Market cap | €3.75m |
| Earnings (TTM) | -€9.80k |
| Revenue (TTM) | €1.50m |
2.5x
P/S Ratio-382.4x
P/E RatioIs H1N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| H1N income statement (TTM) | |
|---|---|
| Revenue | CA$2.20m |
| Cost of Revenue | CA$351.95k |
| Gross Profit | CA$1.84m |
| Other Expenses | CA$1.86m |
| Earnings | -CA$14.34k |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00037 |
| Gross Margin | 83.97% |
| Net Profit Margin | -0.65% |
| Debt/Equity Ratio | -26.5% |
How did H1N perform over the long term?
See historical performance and comparison